Archer Limited (ARCH)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 19.00 |
|---|---|
| 52-week range | 17.56 – 30.25 |
| Return, 1 month / 3 months | −12.2% / −21.3% |
| Return, 1 year / 3 years | −9.0% / +9.9% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -37.5% |
| Average daily value traded | 4.84M NOK |
| Dividend yield | 13.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Archer Limited is an oilfield services company that supplies drilling and well services to oil and gas operators. Its work covers platform drilling, well intervention, coiled tubing, wireline services and the rental of specialised equipment, along with engineering support for wells. The company serves energy companies active in offshore and onshore fields, with operations concentrated around the North Sea and other international regions. Archer is incorporated in Bermuda and runs its main operations from Stavanger, Norway.
The shares are listed on the Oslo Børs in Norway under the code ARCH, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Archer Limited (ARCH) trades on the Oslo Børs in Norway. It last closed at NOK 19.00 on 27 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 202 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.0% and over the last three months it fell 21.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 24 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.4% | ||
| From 52-week high | -35.7% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.3% | ||
| 6-month return | -29.4% | ||
| 12-month return, skipping the last month | 3.7% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.5% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.84M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 13.1% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −13.2% |
|---|---|
| 1 month | −12.2% |
| 3 months | −21.3% |
| 6 months | −29.4% |
| 1 year | −9.0% |
| 3 years | +9.9% |
| 5 years | −50.6% |
Signals
| 50-day / 200-day average | 22.42 / 23.87 |
|---|---|
| Golden / death cross (60 days) | Death, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | NOK 0.6200 |
| 20 May 2026 | NOK 0.6200 |
| 4 Feb 2026 | NOK 0.6200 |
| 6 Nov 2025 | NOK 0.6200 |
| 18 Aug 2025 | NOK 0.6200 |
| 19 May 2025 | NOK 0.6300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.